San Antonio partners pioneer surgery aimed at reversing Type 2 diabetes
April 23, 2021
The goal of the novel procedure is to improve the patients’ health and minimize or reverse the adverse health effects of their Type 2 diabetes.
Category
April 23, 2021
The goal of the novel procedure is to improve the patients’ health and minimize or reverse the adverse health effects of their Type 2 diabetes.
April 9, 2021
The potentially groundbreaking research led by principal investigator Lily Q. Dong, PhD, professor of cell systems and anatomy at UT Health San Antonio, is testing whether there is a genetic marker of early insulin resistance in youth that could be controlled, thereby preventing obesity and development of Type 2 diabetes. Currently, most studies and treatment focus on adults, and pediatric anti-obesity drugs have limited effect.
March 31, 2021
Severely injured trauma patients who received a blood-clotting drug before arriving at the hospital had a better chance of surviving than those who didn’t, according to new research published in Journal of the American Medical Association Surgery.
March 29, 2021
The University of Texas Health Science Center at San Antonio broke ground and unveiled the cornerstone for the UT Health San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of cancer and other complex diseases that disproportionately impact the people of South Texas.
March 26, 2021
According to the study, 53.4% of participants receiving NF were free of cancer at three months and 45.5% of patients continued to be cancer-free for at least 12 months.
March 26, 2021
The surgery, called tracheotomy, is performed either in the operating room or at the bedside, depending on patient risk factors. The team analyzed 17 studies that included more than 3,000 patients.